Agilon Health (NYSE:AGL) Sets New 1-Year High – Here’s Why

Agilon Health, Inc. (NYSE:AGL) shares hit a new 52-week high on Wednesday . The stock traded as high as $72.48 and last traded at $73.9460, with a volume of 70277 shares trading hands. The stock had previously closed at $69.54.

Analyst Upgrades and Downgrades

Several analysts have commented on AGL shares. JPMorgan Chase & Co. downgraded shares of Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 target price for the company. in a research report on Monday, May 4th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Agilon Health in a research note on Monday, April 20th. Robert W. Baird upped their price objective on shares of Agilon Health from $20.00 to $35.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Wall Street Zen raised shares of Agilon Health from a “sell” rating to a “hold” rating in a research report on Saturday. Finally, Deutsche Bank Aktiengesellschaft upgraded Agilon Health from a “hold” rating to a “buy” rating and raised their target price for the company from $33.00 to $49.00 in a report on Thursday, May 7th. Five research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $39.48.

Agilon Health Stock Performance

The company has a market cap of $1.19 billion, a price-to-earnings ratio of -3.32 and a beta of 2.29. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.04 and a quick ratio of 1.04. The firm has a fifty day simple moving average of $21.64 and a 200 day simple moving average of $19.04.

Agilon Health (NYSE:AGL) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $1.80 earnings per share for the quarter, topping analysts’ consensus estimates of $1.04 by $0.76. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. The business had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.38 billion. On average, sell-side analysts expect that Agilon Health, Inc. will post -5.58 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Agilon Health

Several hedge funds and other institutional investors have recently made changes to their positions in AGL. Wealthcare Advisory Partners LLC acquired a new position in shares of Agilon Health during the 3rd quarter worth about $26,000. CIBC Bancorp USA Inc. acquired a new stake in Agilon Health in the 3rd quarter valued at approximately $34,000. Pilgrim Partners Asia Pte Ltd bought a new position in Agilon Health in the 3rd quarter worth approximately $37,000. Tower Research Capital LLC TRC lifted its holdings in shares of Agilon Health by 214.0% during the second quarter. Tower Research Capital LLC TRC now owns 37,079 shares of the company’s stock worth $85,000 after buying an additional 25,270 shares during the last quarter. Finally, Independent Advisor Alliance acquired a new position in shares of Agilon Health during the third quarter worth approximately $39,000.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.